OmniCyte (Biotechnology) Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Out of Business

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Out of Business

OmniCyte (Biotechnology) General Information

Description

Developer of reagents for the treatment of debilitating conditions in humans. The company offers products for the treatment of parkinson's disease, stroke, cirrhosis, diabetes and ischaemic heart disease using stem cell technology.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Du Cane Road
  • Shepherd's Bush
  • London W12 0NN
  • England, United Kingdom
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • Du Cane Road
  • Shepherd's Bush
  • London W12 0NN
  • England, United Kingdom

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OmniCyte (Biotechnology) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Nov-2016 Completed Out of Business
1. Early Stage VC 01-Apr-2014 Completed Startup
To view OmniCyte (Biotechnology)’s complete valuation and funding history, request access »

OmniCyte (Biotechnology) Patents

  • 20

    Total Documents Applications and Grants

  • Total Patents Families

  • 7

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

OmniCyte (Biotechnology) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201021435-D0 Method Inactive 16-Dec-2010
US-20130217125-A1 Culture method Active 06-Oct-2010
US-9163234-B2 Culture method Active 06-Oct-2010
EP-2625267-A2 Culture method for culturing pluripotent cells comprising an inhibitor of mirna-181a* Inactive 06-Oct-2010
GB-201016856-D0 Method Inactive 06-Oct-2010
To view OmniCyte (Biotechnology)’s complete patent history, request access »

OmniCyte (Biotechnology) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

OmniCyte (Biotechnology) FAQs

  • When was OmniCyte (Biotechnology) founded?

    OmniCyte (Biotechnology) was founded in 2003.

  • Where is OmniCyte (Biotechnology) headquartered?

    OmniCyte (Biotechnology) is headquartered in London, United Kingdom.

  • What is the size of OmniCyte (Biotechnology)?

    OmniCyte (Biotechnology) has 7 total employees.

  • What industry is OmniCyte (Biotechnology) in?

    OmniCyte (Biotechnology)’s primary industry is Biotechnology.

  • Is OmniCyte (Biotechnology) a private or public company?

    OmniCyte (Biotechnology) is a Private company.

  • What is OmniCyte (Biotechnology)’s current revenue?

    The current revenue for OmniCyte (Biotechnology) is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »